Aspargo Labs Inc.
Sildenafil Oral Spray
Erectile Dysfunction Market
The market is expected to continue its growth. The Americas is the largest market with North America larger than South America due to advanced technology and advanced medical facilities. This factor enables North America to emerge as the largest market on its own. All kinds of advanced medical facilities make North America an ideal market and hence, all kinds of drugs including erectile dysfunction drugs remain in demand.
Growing Demand for ED Drugs
Prescription oral suspension Sildenafil is supported by proven technology.
Real World Prescription Patterns for PDE5 Inhibitors
Treatment Initiation
VIAGRA® was the most frequently prescribed PDE5 inhibitor for initial pharmacologic treatment of ED (2010 – 2015)
ED, erectile dysfunction, PDE5, phosphodiesterase type 5 Mulhall JP, et al. J Sex Med. 2020 Mar 3. doi: 10.1016/j.jsxm.2020.01.027.
Enhanced Administration
Convenient administration in discreet, pocket-size pump container without the need for accompanying liquids.
Pleasant mint taste.
Flexible Dosing
Measured dose in each pump of spray allows flexible dosing tailored to individual patients’ level of dysfunction.
Reduces occurrence of adverse events and need to divide single tablets.
Dysphagia Accessible
Allows dosing for patients suffering from dysphagia (difficulty swallowing), a condition prevalent in elderly adults associated with comorbid health conditions.
Neonatal Friendly
Convenient administration for newborns suffering from persistent pulmonary hypertension (PPHN), a failure of the normal circulatory transition that occurs after birth.
Footer
Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining our innovative science and technologies with FDA’s 505(b)(2) approval pathway and corresponding regulations in international jurisdictions to enhance currently marketed drugs with well-known pharmacology profiles.